How we work
We reduce avoidable late-stage risk by connecting methodology, data, software intended use and regulatory documentation early.
Stages
Most engagements follow five stages. Depth and duration depend on scope — a focused writing surge is not the same as a multi-year software programme.
- Discover — goals, constraints, evidence gaps, stakeholders and what “done” must look like for the client’s next decision
- Frame — written scope, exclusions, owners and success criteria; dual-market differences named early when EU and US both matter
- Build — methods, software and/or documentation increments tied to that frame (not parallel silos)
- Harden — review readiness, traceability, risk notes and consistency across contributing functions
- Hand over — next steps, artefacts and open questions
What “connected” means
Life-sciences programmes fail quietly when methodology, software intended use and regulatory documentation diverge. We keep those tracks in dialogue so late surprises are less likely.
- Scientific questions and estimands influence analysis and protocol structure
- Intended use influences architecture, risk controls and claims language
- Regulatory packages inherit technical sources instead of inventing a second story
Engagement models
- Advisory — focused reviews, design options, pathway framing
- Project-based — defined deliverables and timeline (e.g. protocol package, software increment, submission writing surge)
- Retained / surge support — ongoing capacity when programmes need recurring biometrics, engineering or RA writing help
Commercial details are agreed per proposal. Contracting entities and privacy routing follow the site region you select (see Imprint).
What good handoff looks like
- Artefacts the client can own inside their QMS / ALM / document control
- Explicit open questions and owners — not tribal knowledge
- Clear owners for what the client takes forward
Explore further
Ready to discuss a programme?
Tell us about your organisation and the type of support you need.